Hosted on MSN
Mastering sequencing QC for flawless runs
From Illumina to Nanopore to PacBio, getting high-quality sequencing data starts long before the run begins. Careful library prep, accurate quantification, platform-specific QC checks, and novel RNA ...
StockStory.org on MSN
ILMN Q1 deep dive: Clinical sequencing fuels growth as NovaSeq X demand surges
Genomics company Illumina (NASDAQ:ILMN) reported Q1 CY2026 results , with sales up 4.8% year on year to $1.09 billion. The ...
Management raised full-year guidance, with Dhingra stating, "We are raising our reported revenue guidance by $20 million... and now expect revenue of $4.52 billion to $4.62 billion" and "now expect ...
With the strong start to the year, Illumina bumped up its guidance. It now expects revenue between $4.52 billion and $4.62 billion, up $20 million at the midpoint versus its prior guidance. It now ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results